Novus Entertainment

Global Direct-fed Microbials (DFM) Market Analysis & Outlook (2017-2026) - ResearchAndMarkets.com

Retrieved on: 
Friday, April 26, 2019
Manufacturing, Chemicals, Plastics, Kemin Industries, Novus Entertainment, Telecommunications

The "Direct-fed Microbials (DFM) - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Direct-fed Microbials (DFM) - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.
  • According to this report, the Global Direct-Fed Microbial market accounted for $1,017.67 million in 2017 and is expected to reach $2,192.09 million by 2026 growing at a CAGR of 8.9% during the forecast period.
  • However, varying regulations pertaining to consumption of bacteria in food and feed are restraining the market.
  • Some of the key players profiled in the Direct-Fed Microbials Market include Novus International, Inc., Novozymes, Archer Daniels Midland Company, Kemin Industries, Inc., Dupont, Chr.

Novus Health, Global Leader in Health Navigation, Takes Member Health and Safety on the Road with Travel Navigator™

Retrieved on: 
Tuesday, April 16, 2019
Articles, Contents, Broadband, Novus Entertainment, Health care, Novus, Health, Telecommunications, Robin Ingle

With more organizations functioning on a global scale, Novus Health complements their health navigation products with a mobile travel-related service.

Key Points: 
  • With more organizations functioning on a global scale, Novus Health complements their health navigation products with a mobile travel-related service.
  • Travel Navigator enhances the health information provided by Novus Health to include safety and security support to global travellers all in an easy-to-use mobile application.
  • For this reason, Novus Health includes Travel Navigator in its suite of products and services.
  • Travel Navigator is owned and maintained by Health Care Services International Inc.
    Novus Health is a leader in health navigation.

Allion USA Announces Corporate Name Change to Novus Labs, Expands Services

Retrieved on: 
Tuesday, February 26, 2019
Broadband, Novus Entertainment, Engineering, Articles, Telecommunications

HILLSBORO, Ore., Feb. 26, 2019 /PRNewswire/ --Allion USA a global leader in engineering services today announced it is changing its corporate name to Novus Labs.

Key Points: 
  • HILLSBORO, Ore., Feb. 26, 2019 /PRNewswire/ --Allion USA a global leader in engineering services today announced it is changing its corporate name to Novus Labs.
  • With unmatched flexibility coupled with a unique breadth of engineering services, Novus Labs offers world-class development, testing and staffing across product categories with uniquely qualified engineering talent.
  • "Our name change is an opportunity to differentiate ourselves from others in the industry that are more limited in scope.
  • With a variety of technology experts on staff, Novus Labs is a global leader in engineering services, development and technical staffing.

Novus Therapeutics to Participate in the 8th Annual SVB Leerink Global Healthcare Conference

Retrieved on: 
Wednesday, February 20, 2019
Health, Biotechnology, Pharmaceutical, Otorhinolaryngology, Novus Entertainment, ENT, Leerink Partners, Novus, Sinus, Telecommunications, Information and communications technology

Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced that the company will participate at the 8th Annual SVB Leerink Healthcare Conference on Thursday, February 28, 2019 at the Lotte New York Palace, New York.

Key Points: 
  • Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced that the company will participate at the 8th Annual SVB Leerink Healthcare Conference on Thursday, February 28, 2019 at the Lotte New York Palace, New York.
  • Novus Therapeutics, Inc. (Novus) is a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT).
  • Novus has two technologies, each that has the potential to be developed for multiple ENT indications.
  • Novus also has a foam-based drug delivery technology (OP0102), which may be developed in the future to deliver drugs into the ear, nasal, and sinus cavities.

Novus Employees Surpass Goal for Local Giving

Retrieved on: 
Tuesday, November 27, 2018
Income statement, Economy, Payroll, Broadband, Novus Entertainment, Novus International, Novus, Income, Fundraising, United Way Worldwide

ST. LOUIS, Nov. 27, 2018 /PRNewswire/ -- Since its formation, Novus International, Inc. and its employees have been working to support charities in their local communities through the United Way.

Key Points: 
  • ST. LOUIS, Nov. 27, 2018 /PRNewswire/ -- Since its formation, Novus International, Inc. and its employees have been working to support charities in their local communities through the United Way.
  • Every year, the Novus offices in the United States collaborate on a fundraising campaign to help support local organizations through the United Way.
  • The teams host events such as raffles and bingo to a golf tournament that brings Novus employees and business partners together to help support the local communities in which Novus does business.
  • Novus employees also generously pledge dollars to the cause through one-time donations as well as payroll deductions.